Demethylating agents were also shown to induce in tumor cells cancer/ testis and viral antigens, that may represent a target for humoral and CD8+ T immune response against tumor, providing opportunities for immunotherapeutic targeting [60, 61]. Here, CD8A is linked to neoplasm.